Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia | Zendy

Donovan T. Maust | Zendy; Hyungjin Myra Kim | Zendy; Lisa S. Seyfried | Zendy; Claire Chiang | Zendy; Janet Kavanagh | Zendy; Lon S. Schneider | Zendy; Helen C. Kales | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia

Author(s) -

Donovan T. Maust,

Hyungjin Myra Kim,

Lisa S. Seyfried,

Claire Chiang,

Janet Kavanagh,

Lon S. Schneider,

Helen C. Kales

Publication year - 2015

Publication title -

jama psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.531

H-Index - 365

eISSN - 2168-6238

pISSN - 2168-622X

DOI - 10.1001/jamapsychiatry.2014.3018

Subject(s) - quetiapine , olanzapine , risperidone , medicine , dementia , antipsychotic , relative risk , number needed to harm , typical antipsychotic , psychiatry , atypical antipsychotic , antidepressant , haloperidol , schizophrenia (object oriented programming) , confidence interval , number needed to treat , disease , dopamine , hippocampus

Antipsychotic medications are associated with increased mortality in older adults with dementia, yet their absolute effect on risk relative to no treatment or an alternative psychotropic is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research